Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neptune Technologies & Bioressources Inc (NASDAQ:NEPT)

1.35
Delayed Data
As of Aug 28
 +0.02 / +1.50%
Today’s Change
1.11
Today|||52-Week Range
2.42
-28.95%
Year-to-Date
No recent news for Neptune Technologies & Bioressources Inc.

Today’s Trading

Previous close1.33
Today’s open1.32
Day’s range1.32 - 1.43
Volume32,460
Average volume (3 months)81,581
Market cap$100.3M
Dividend yield--
Data as of 3:51pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)-30.89%
Earnings growth (this year)+52.13%
Earnings growth (next 5 years)--
Revenue growth (last year)-28.12%
P/E ratio--
Price/Sales10.39
Price/Book2.03

Competitors

 Today’s
change
Today’s
% change
VBLTVascular Biogenics L...-0.11-2.03%
DNAIProNAi Therapeutics ...+1.72+6.07%
DEPODepomed Inc-0.42-1.46%
TEVATeva Pharmaceutical-0.17-0.26%
Data as of 4:02pm ET, 08/28/2015

Financials

Next reporting dateOctober 13, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$13.4M
Annual profit (last year)-$24.8M
Net profit margin-185.54%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Jim Hamilton
Chief Financial Officer
Mario Paradis
Corporate headquarters
Laval, Quebec

Forecasts

Partner Offers